[1]常 阳,郑 鑫,施鸿金,等.尿源性脓毒症早期预警指标研究进展[J].陕西医学杂志,2025,54(5):707-710.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.027]
　CHANG Yang,ZHENG Xin,SHI Hongjin,et al.Research progress on early warning indicators for urosepsis[J].,2025,54(5):707-710.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.027]
点击复制

尿源性脓毒症早期预警指标研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年5期
页码:
707-710
栏目:
综 述
出版日期:
2025-05-05

文章信息/Info

Title:
Research progress on early warning indicators for urosepsis
作者:
常 阳1; 郑 鑫1; 施鸿金2; 王海峰2; 邰文琳1; 李劲榆1
(1.昆明医科大学第二附属医院检验科,云南 昆明 650101; 2.昆明医科大学第二附属医院泌尿外科,云南 昆明 650101)
Author(s):
CHANG Yang1; ZHENG Xin1; SHI Hongjin2; WANG Haifeng2; TAI Wenlin1; LI Jinyu1
(1.Department of Clinical Labroratory,the Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China; 2.Department of Urology,the Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China)
关键词:
尿源性脓毒症;  早期预警;  生物标志物;  全身炎症反应综合征;  早期诊断
Keywords:
Urosepsis;  Early warning;  Biomarkers;  Systemic inflammatory response syndrome;  Early diagnosis
分类号:
R 631
DOI:
DOI:10.3969/j.issn.1000-7377.2025.05.027
文献标志码:
A
摘要:
尿源性脓毒症是一种由泌尿系统感染引起的脓毒血症,是泌尿外科和重症监护室常见的危重疾病之一,具有死亡率高和病情进展迅速的特点,若诊治不及时,可发展为脓毒性休克,导致患者多器官功能衰竭甚至死亡。尽管早期干预对改善患者预后至关重要,但目前仍缺乏特异性和敏感性较高的诊断标准。近年来,新兴的生物标志物在尿源性脓毒症的早期识别中展现出巨大潜力。现对尿源性脓毒症相关的早期预警生物标志物及其诊断性能和临床价值进行综述,为尿源性脓毒症的早期诊断提供新的视角与策略。
Abstract:
Urosepsis,a type of sepsis caused by urinary tract infections,is a common critical illness in urology and intensive care units,characterized by high mortality and rapid disease progression.If not diagnosed and treated promptly,it can progress to septic shock,leading to multiple organ dysfunction syndrome and even death.Despite the importance of early intervention in improving patient outcomes,current diagnostic criteria lack sufficient specificity and sensitivity.In recent years,emerging biomarkers have shown great potential in the early identification of urosepsis.This article reviews the early warning biomarkers related to urosepsis,their diagnostic performance,and clinical value,aiming to provide new perspectives and strategies for the early diagnosis of urosepsis.

参考文献/References:

[1] TANDOGDU Z,KOVES B,RISTOVSKI S,et al.Urosepsis 30-day mortality,morbidity,and their risk factors:SERPENS study,a prospective,observational multi-center study[J].World J Urol,2024,42(1):314.
[2] LEE J H,KIM S H,JANG J H,et al.Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock[J].Medicine(Baltimore),2022,101(48):e31895.
[3] SINGER M,DEUTSCHMAN C S,SEYMOUR C W,et al.The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J].JAMA,2016,315(8):801-810.
[4] GULICIUC M,MAIER A C,MAIER I M,et al.The urosepsis-a literature review[J].Medicina(Kaunas),2021,57(9):872.
[5] QIU X,LEI Y P,ZHOU R X.SIRS,SOFA,qSOFA,and NEWS in the diagnosis of sepsis and prediction of adverse outcomes:A systematic review and meta-analysis[J].Expert Rev Anti Infect Ther,2023,21(8):891-900.
[6] ZHU C L,WANG Y,LIU Q,et al.Dysregulation of neutrophil death in sepsis[J].Front Immunol,2022,13:963955.
[7] JOFFRE J,HELLMAN J,INCE C,et al.Endothelial responses in sepsis[J].Am J Respir Crit Care Med,2020,202(3):361-370.
[8] LI Z,YIN M,ZHANG H,et al.BMX represses thrombin-PAR1-mediated endothelial permeability and vascular leakage during early sepsis[J].Circ Res,2020,126(4):471-485.
[9] 董学广,傅晓夏,陈秀美,等.解毒通腑泻浊汤保留灌肠对脓毒症合并急性肾损伤患者微循环及血清炎性应激指标的影响[J].陕西中医,2022,43(10):1388-1391.
[10] 谢琼燕,许环清,叶文,等.生物标志物预测脓毒症引发急性肾损伤临床研究[J].陕西医学杂志,2023,52(7):880-884.
[11] 邱来春,王金霞,王先技,等.经皮肾镜碎石术后患者尿源性脓毒血症的影响因素分析[J].中华医院感染学杂志,2018,28(6):896-899.
[12] 钟传华,晏恒馨,黄华,等.恒压灌注下微通道经皮肾镜取石术后尿脓毒血症风险评分系统的初步建立[J].现代泌尿外科杂志,2021,26(8):655-659,677.
[13] REHMAN F U,KHAN A,AZIZ A,et al.Neutrophils to lymphocyte ratio:Earliest and efficacious markers of sepsis[J].Cureus,2020,12(10):e10851.
[14] VILLANUEVA-CONGOTE J,HINOJOSA-GONZALEZ D,SEGALL M,et al.The relationship between neutrophil/ly-mphocyte ratio,platelet/neutrophil ratio,and risk of urosepsis in patients who present with ureteral stones and suspected urinary tract infection[J].World J Urol,2024,42(1):596.
[15] 吴泽华,李跃东,戴莹莹,等.降钙素原、C反应蛋白、白细胞计数和中性粒细胞比率在重症医学科脓毒症治疗预后判断中的临床价值[J].陕西医学杂志,2024,53(4):540-543.
[16] BLANGY-LETHEULE A,PERSELLO A,ROZEC B,et al.New approaches to identify sepsis biomarkers:The importance of model and sample source for mass spectrometry[J].Oxid Med Cell Longev,2020,2020:6681073.
[17] VIJAYAN A L,VANIMAYA,RAVINDRAN S,et al.Procalcitonin:A promising diagnostic marker for sepsis and antibiotic therapy[J].J Intensive Care,2017,5:51.
[18] VELISSARIS D,ZAREIFOPOULOS N,LAGADINOU M,et al.Procalcitonin and sepsis in the emergency department:An update[J].Eur Rev Med Pharmacol Sci,2021,25(1):466-479.
[19] SAMSUDIN I,VASIKARAN S D.Clinical utility and measurement of procalcitonin[J].Clin Biochem Rev,2017,38(2):59-68.
[20] ZHANG W,WANG W,HOU W,et al.The diagnostic utility of IL-10,IL-17,and PCT in patients with sepsis infection[J].Front Public Health,2022,10:923457.
[21] SUN L,ZHU H,ZHANG K.GAB1 alleviates septic lung injury by inhibiting the TLR4/NF-κB pathway[J].Clin Exp Pharmacol Physiol,2022,49(1):94-103.
[22] REN G,LIU R,MAI H,et al.GAB1 attenuates lipopolysaccharide-mediated endothelial dysfunction via regulation of SOCS3[J].Exp Ther Med,2024,28(4):400.
[23] PAUDEL S,BARAL P,GHIMIRE L,et al.CXCL1 regulates neutrophil homeostasis in pneumonia-derived sepsis caused by Streptococcus pneumoniae serotype 3[J].Blood,2019,133(12):1335-1345.
[24] ZHAO R,LI H,XU B,et al.CXCL5 as a biomarker for early diagnosis and prognosis of sepsis:A comprehensive clinical evaluation[J].Clinical biochemistry,136:110878.
[25] CHEN W,WANG Y,ZHOU Y,et al.M1 macrophages increase endothelial permeability and enhance p38 phosphorylation via PPAR-γ/CXCL13-CXCR5 in sepsis[J].Int Arch Allergy Immunol,2022,183(9):997-1006.
[26] PEI Y,ZHOU G,WANG P,et al.Serum cystatin C,kidney injury molecule-1,neutrophil gelatinase-associated lipocalin,klotho and fibroblast growth factor-23 in the early prediction of acute kidney injury associated with sepsis in a Chinese emergency cohort study[J].Eur J Med Res,2022,27(1):39.
[27] ZHANG C F,WANG H J,TONG Z H,et al.The diagnostic and prognostic values of serum and urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in sepsis induced acute renal injury patients[J].Eur Rev Med Pharmacol Sci,2020,24(10):5604-5617.
[28] PAUL A,NEWBIGGING N S,LENIN A,et al.Role of neutrophil gelatinase-associated lipocalin(NGAL)and other clinical parameters as predictors of bacterial sepsis in patients presenting to the emergency department with fever[J].Indian J Crit Care Med,2023,27(3):176-182.
[29] BI S,LIU Z,WU Z,et al.SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer[J].Protein Cell,2020,11(7):483-504.
[30] 曹佳,杨华英,何艺,等.姜黄素通过激活SIRT1调节脓毒症小鼠模型的认知功能障碍研究[J].陕西中医,2020,41(3):301-307.
[31] WANG Q,XU J,LI X,et al.Sirt3 modulate renal ischemia-reperfusion injury through enhancing mitochondrial fusion and activating the ERK-OPA1 signaling pathway[J].J Cell Physiol,2019,234(12):23495-23506.
[32] LIU J,ZHOU G,CHEN R,et al.Mitochondrial Sirt3 serves as a biomarker for sepsis diagnosis and mortality prediction[J].Sci Rep,2022,12(1):10414.
[33] PARASKEVAS T,CHOURPILIADI C,DEMIRI S,et al.Presepsin in the diagnosis of sepsis[J].Clin Chim Acta,2023,550:117588.
[34] MEMAR M Y,BAGHI H B.Presepsin:A promising biomarker for the detection of bacterial infections[J].Biomed Pharmacother,2019,111:649-656.
[35] PICCIONI A,SANTORO M C,DE-CUNZO T,et al.Presepsin as early marker of sepsis in emergency department:A narrative review[J].Medicina(Kaunas),2021,57(8):770.

相似文献/References:

[1]张克恭,张 野,武小青,等.中性粒细胞与肾综合征出血热危重化关系临床研究[J].陕西医学杂志,2020,49(6):695.[doi:DOI:10.3969/j.issn.10007377.2020.06.014]

备注/Memo

备注/Memo:
[基金项目]国家自然科学基金资助项目(82260609)
更新日期/Last Update: 2025-05-05